Search Results - B. Ya. Bart

  • Showing 1 - 17 results of 17
Refine Results
  1. 1
  2. 2
  3. 3

    Clinical implications of osteoporosis in chronic heart failure by V. N. Larina, B. Ya. Bart, T. N. Raspopova

    Published 2013-04-01

    The paper focusses on the problem of impaired bone metabolism in patients with chronic heart failure. The authors discuss the importance of this problem, prevalence of osteoporosis, pathophysiological mechanisms of bone metabolism impairment, and common risk factors of heart failure and osteoporosis...

    Full description

    Get full text
    Article
  4. 4

    CARDIAC REMODELLING AND CLINICAL PROGNOSIS IN PATIENTS WITH CHRONIC HEART FAILURE AND COMPLETE LEFT BUNDLE BRANCH BLOCK by B. Ya. Bart, V. N. Larina, M. S. Brodskyi

    Published 2011-12-01

    Aim: To investigate echocardiography (EchoCG) parameters and clinical prognosis in elderly patients with chronic heart failure (CHF) and complete left bundle branch block (LBBB). Material and methods: The study included 248 patients (163 men and 85 women), aged 60–85 years, with Functional Class II–...

    Full description

    Get full text
    Article
  5. 5
  6. 6

    Chronic arterial hypertension and its clinical course at various pregnancy stages (247hour blood pressure monitoring data) by N. K. Runikhina, M. P. Mikhaylusova, B. Ya. Bart

    Published 1970-01-01

    Aim. То study circadian blood pressure (ВР) profile in chronic arterial hypertension (САП) at various pregnancy stages. Material and metliods. In total, 61 pregnant women with САH (mean age 27,9±0,8 years) were recruited in the main group. Control group included 50 normotensive pregnant women. All С...

    Full description

    Get full text
    Article
  7. 7

    Nifedipine effects on blood cells and rheology in arterial hypertension and pregnancy by N. K. Runikhina, O. N. Tkacheva, B. Ya. Bart

    Published 2007-12-01

    Arterial hypertension (AH) in pregnancy is associated with systemic endothelial damage, vasoconstriction, and blood rheology disturbances, that results in microcirculation disorders, tissue and organ ischemia. Antihypertensive therapy effects on endothelium and blood cells in hypertensive pregnant w...

    Full description

    Get full text
    Article
  8. 8

    ANEMIC SYNDROME IN PATIENTS WITH CHRONIC HEART FAILURE by V. N. Larina, B. Ya. Bart, E. L. Balabanova

    Published 2010-06-01

    The prevalence of anemia and its effects on chronic heart failure (CHF) course in ambulatory patients of various age were examined. The study included 282 patients (86 women, 196 men) with NYHA Functional Class (FC) II-II CHF, aged from 39 to 85 years (median age 67 [62-73] years). In CHF patients,...

    Full description

    Get full text
    Article
  9. 9

    FACTORS EFFECTING THE DECOMPENSATION OF CHRONIC HEART FAILURE IN THE ELDERLY by V. N. Larina, B. Ya. Bart, E. A. Vartanyan

    Published 2015-09-01

    Aim. To identify risk factors of decompensation of chronic heart failure (CHF) and related hospitalization in elderly outpatients.Material and methods. The total of 248 patients aged 60–85 years with CHF NYHA class II-IV were enrolled into the study. The first group consisted of 87 (35.1%) patients...

    Full description

    Get full text
    Article
  10. 10

    CLINICAL SIGNIFICANCE OF ANEMIC SYNDROME IN PATIENTS WITH CHRONIC HEART FAILURE by V. N. Larina, B. Ya. Bart, V. G. Larin

    Published 2016-01-01

    Aim. To evaluate the anemia prevalence and its impact on chronic heart failure (CHF) course.Methods. A total of 228 outpatients (86 women and 196 men, aged 39-85 y.o.) with clinically stable CHF (II-IV functional class according to NYHA) were studied. Anemia was defined by the WHO criteria (hemoglob...

    Full description

    Get full text
    Article
  11. 11

    Calcium antagonist nifedipine in treating pregnant women with arterial hypertension: pro and contra by N. K. Runikhina, B. Ya. Bart, O. N. Tkacheva

    Published 2007-04-01

    Calcium antagonist nifedipine, an antihypertensive and anti-anginal medication with vasodilating action, is widely used in cardiology practice. According to the recommendations on cardiovascular disease management in pregnancy, by the European Society of Cardiology (2003) and Society of Cardiology o...

    Full description

    Get full text
    Article
  12. 12

    Left atrium structural and functional changes in arterial hypertension, and their dynamics during pharmacotherapy by B. Ya. Bart, E. A. Vartanyan, E. N. Dergunova, T. I. Skakova

    Published 2004-04-01

    This study was conducted to investigate principal structural and functional parameters of left atrium (LA), and to evaluate the effects of combined hypotensive therapy in AH patients. Fifty-eight patients with Stage I and II AH, receving low- and moderate-dose combined therapy, as well as 30 healthy...

    Full description

    Get full text
    Article
  13. 13

    EARLY ECHOCARDIOGRAPHIC MARKERS OF STRUCTURAL AND FUNCTIONAL RIGHT VENTRICULAR REMODELLING IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE by B. Ya. Bart, E. N. Dergunova, E. A. Vartanyan, O. M. Kulbachinskaya

    Published 2012-06-01

    Aim. To study right ventricular (RV) structure and function, as well as cardiac and pulmonary hemodynamic parameters, in patients with chronic obstructive pulmonary disease (COPD) of moderate severity. Material and methods. The study included 37 COPD patients and 20 healthy controls. All participant...

    Full description

    Get full text
    Article
  14. 14

    TISSUE DOPPLEROGRAPHY AND THE ASSESSMENT OF RIGHT HEART STRUCTURE AND FUNCTION IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE by B. Ya. Bart, O. M. Kulbachinskaya, E. N. Dergunova, E. A. Vartanyan

    Published 2014-02-01

    Aim. To assess the status of right heart structure and function in patients with mild chronic obstructive pulmonary disease (COPD).Material and methods. The study included 56 COPD patients and 26 healthy volunteers. All participants underwent lung function assessment and echocardiography.Results. Ba...

    Full description

    Get full text
    Article
  15. 15
  16. 16

    Ergoferon and Oseltamivir in Treatment of Influenza: Results of Multicentre Randomized Comparative Clinical Trial by A. V. Averyanov, A. P. Babkin, B. Ya. Bart, A. L. Volchetsky, E. S. Minina, O. A. Kozyrev, M. P. Kostinov, D. V. Petrov, E. P. Selkova, M. A. Putilovsky, V. B. Nechaev, O. I. Epstein, E. N. Andrianova

    Published 2020-05-01

    The narrow range of choice and virus resistance to the most common drugs require search and introduction of new drugs with proven efficacy and safety for the treatment of influenza. Ergoferon is a new combined medicine containing release active antibodies to interferon-γ (anti-IFNγ), CD4-coreceptor...

    Full description

    Get full text
    Article
  17. 17

    Treatment of acute respiratory infection in adults: results of a multicenter randomized double-blind placebo-controlled clinical trial by M. P. Kostinov, R. F. Khamitov, A. P. Babkin, E. S. Minina, B. Ya. Bart, M. P. Mikhailusova, M. E. Yanovskaya, A. O. Sherenkov, D. V. Petrov, D. N. Alpenidze, Yu. S. Shapovalova, M. V. Chernogorova, E. F. Pavlysh, R. T. Sardinov

    Published 2021-06-01

    The results of a multicenter randomized double-blind placebo-controlled clinical trial in parallel groups carried out in 2012–2015 aimed to reveal the efficacy and safety of the antiviral drug ergoferon in the treatment of acute respiratory tract infection in adults are presented.

    Get full text
    Article